Table 1: Patient and eye characteristics.
|
Sex |
Age |
Preope VA |
postope VA |
Post-pre VA |
Ocular comorbidities |
Intra-ope complications |
Post-ope complications |
Dementia |
Underlying disease |
Living environment |
1 |
F |
95 |
1.4 |
0.22 |
-1.18 |
- |
- |
- |
- |
CAB |
family |
2 |
M |
95 |
0.22 |
0 |
-0.22 |
- |
- |
- |
- |
CI |
family |
3 |
F |
95 |
0.82 |
0.046 |
-0.774 |
- |
- |
- |
- |
RA, HT |
family |
4[3] |
F |
95 |
0.7 |
0 |
-0.7 |
- |
PCR |
- |
- |
RA, HT |
family |
5 |
M |
94 |
0.7 |
0.22 |
-0.48 |
- |
- |
- |
- |
HT, DM, CVD, CRF, HD |
family |
6[5] |
M |
94 |
1.7 |
0.22 |
-1.48 |
- |
- |
- |
- |
HT, DM, CVD, CRF, HD |
family |
7 |
M |
93 |
2 |
0.52 |
-1.48 |
AMD |
- |
- |
- |
DM |
family |
8 |
F |
93 |
0.4 |
-0.08 |
-0.48 |
- |
- |
- |
- |
HT, CSH |
alone |
9[8] |
F |
93 |
0.22 |
-0.08 |
-0.3 |
- |
- |
- |
- |
HT, CSH |
alone |
10 |
F |
92 |
2.3 |
0.046 |
-2.254 |
- |
ACT |
- |
+ |
MI, AF |
alone |
11 |
M |
91 |
0.22 |
0 |
-0.22 |
- |
- |
- |
- |
HT, DM, AF |
alone |
12 |
F |
91 |
0.3 |
0.15 |
-0.15 |
- |
- |
- |
- |
HT, AS, SAS |
family |
13[12] |
F |
91 |
0.15 |
0.01 |
-0.14 |
- |
- |
- |
- |
HT, AS, SAS |
family |
14 |
M |
91 |
1.1 |
0.82 |
-0.28 |
gla |
- |
- |
- |
HT, AMI |
alone *2 |
15 |
F |
90 |
0.7 |
0.52 |
-0.18 |
*1 |
- |
HIOP |
+ |
HT, HL |
alone *3 |
16 |
M |
90 |
1.5 |
0.52 |
-0.98 |
- |
- |
- |
- |
DM, CI |
aged |
17[16] |
M |
90 |
1.5 |
0.52 |
-0.98 |
- |
- |
- |
- |
DM, CI |
aged |
18 |
F |
90 |
1.7 |
0.01 |
-1.69 |
- |
- |
- |
- |
- |
family |
19[18] |
F |
90 |
0.52 |
0.3 |
-0.22 |
- |
- |
- |
- |
- |
family |
20 |
F |
90 |
0.4 |
0.15 |
-0.25 |
- |
- |
- |
- |
CI |
aged |
21[20] |
F |
90 |
0.4 |
0.15 |
-0.25 |
- |
- |
- |
- |
CI |
aged |
22 |
M |
90 |
0.15 |
-0.18 |
-0.33 |
- |
- |
- |
- |
CI, AF |
family |
23 |
F |
90 |
0.4 |
0.15 |
-0.25 |
ERM, gla |
- |
- |
- |
LSS |
aged |
24 |
F |
90 |
0.3 |
0.15 |
-0.15 |
gla |
- |
- |
- |
DM, MI |
family |
25 |
F |
90 |
0.7 |
0.15 |
-0.55 |
- |
- |
- |
- |
HT, HL |
alone |
*1: Severe phacodonesis and zonulolysis; *2: At another hospital for postoperative management; *3: In short stay for postoperative management